Your browser doesn't support javascript.
loading
Circ_CEA promotes the interaction between the p53 and cyclin-dependent kinases 1 as a scaffold to inhibit the apoptosis of gastric cancer.
Yuan, Yuan; Zhang, Xiaojing; Du, Kaining; Zhu, Xiaohui; Chang, Shanshan; Chen, Yang; Xu, Yidan; Sun, Jiachun; Luo, Xiaonuan; Deng, Shiqi; Qin, Ying; Feng, Xianling; Wei, Yanjie; Fan, Xinmin; Liu, Ziyang; Zheng, Baixin; Ashktorab, Hassan; Smoot, Duane; Li, Song; Xie, Xiaoxun; Jin, Zhe; Peng, Yin.
Afiliação
  • Yuan Y; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China.
  • Zhang X; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China.
  • Du K; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China.
  • Zhu X; Department of Pharmacology, College of Pharmacy, Shenzhen Technology University, Shenzhen, Guangdong, 518118, People's Republic of China.
  • Chang S; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China.
  • Chen Y; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China.
  • Xu Y; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China.
  • Sun J; The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Henan Key Laboratory of Cancer Epigenetics, No. 24, Jinhua Road, Jianxi District, Luoyang, Henan, 471003, People's Republic of China.
  • Luo X; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China.
  • Deng S; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China.
  • Qin Y; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, Guangdong, 518000, People's Republic of China.
  • Feng X; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China.
  • Wei Y; Center for High Performance Computing, Shenzhen Institutes of Advanced Technology, Shenzhen, Guangdong, 518000, People's Republic of China.
  • Fan X; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China.
  • Liu Z; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China.
  • Zheng B; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China.
  • Ashktorab H; Department of Medicine and Cancer Center, Howard University, College of Medicine, Washington, DC, 20060, USA.
  • Smoot D; Department of Medicine, Meharry Medical Center, Nashville, TN, 37208, USA.
  • Li S; Shenzhen Science & Technology Development Exchange Center, Shenzhen, Guangdong, 518055, People's Republic of China.
  • Xie X; School of Basic Medical Sciences, Guangxi Medical University, Nanning, 530021, Guangxi, People's Republic of China.
  • Jin Z; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China.
  • Peng Y; Guangdong Provincial Key Laboratory of Genome Stability and Disease Prevention and Regional Immunity and Diseases, Department of Pathology, Shenzhen University Health Science Center, Shenzhen, Guangdong, 518060, People's Republic of China. ypeng@szu.edu.cn.
Cell Death Dis ; 13(9): 827, 2022 09 27.
Article em En | MEDLINE | ID: mdl-36167685
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / MicroRNAs Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / MicroRNAs Idioma: En Ano de publicação: 2022 Tipo de documento: Article